SCHEMBL31410889

SCHEMBL31410889

CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 4/20 0.47
▸ NTSR1 P30989 4/20 0.44
▸ NTSR2 O95665 1/20 0.44
▸ XIAP P98170 1/20 0.44
▸ OPRD1 P41143 2/20 0.43
▸ KEAP1 Q14145 2/20 0.43
▸ NPY2R P49146 1/20 0.41
▸ NPY4R P50391 1/20 0.41
▸ NPY5R Q15761 1/20 0.41
▸ F2 P00734 2/20 0.40
▸ CAPN1 P07384 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31410849 0.85 CAPN1 (0.45) NTSR1NTSR2XIAPCAPN1
SCHEMBL30102062 0.84 XIAP (0.43) NPY1RXIAPKEAP1NPY2RNPY4R
SCHEMBL31235878 0.81 NTSR1 (0.48) NPY1RNTSR1NTSR2XIAPNPY2R
SCHEMBL30586481 0.80 XIAP (0.53) NPY1RNTSR1NTSR2XIAPNPY2R
SCHEMBL29407478 0.80 REN (0.44) NTSR1NTSR2OPRD1CAPN1
SCHEMBL31235886 0.79 XIAP (0.45) NPY1RNTSR1NTSR2XIAPKEAP1
SCHEMBL30627045 0.78 KEAP1 (0.39) XIAPOPRD1KEAP1
SCHEMBL31235876 0.78 NTSR1 (0.48) NPY1RNTSR1NTSR2XIAPNPY2R
SCHEMBL30695673 0.78 NTSR1 (0.44) NPY1RNTSR1NTSR2OPRD1KEAP1
SCHEMBL30414011 0.78 CAPN1 (0.44) NTSR1NTSR2XIAPOPRD1CAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025002589-A1 TISSUE EXTRACELLULAR PEPTIDE PATTERNS DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST SALIVARY GLAND TUMOR, IDENTIFICATION AND ISOLATION OF SALIVARY GLAND TUMOR SPECIFIC T CELLS IN HUMANS Uniwersytet Gdański (PL) 2025-01-02 — — WO disclosed
Send feedback